Ionis Pharmaceuticals IONS Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's common stock, shares authorized (in shares)?
- Ionis Pharmaceuticals (IONS) reported common stock, shares authorized (in shares) of $300M in Q1 2026.
- How has Ionis Pharmaceuticals's common stock, shares authorized (in shares) changed year-over-year?
- Ionis Pharmaceuticals's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $300M to $300M.
- What is the long-term trend for Ionis Pharmaceuticals's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $300M to $300M.